Healthcare >> Analyst Interviews >> January 10, 2001
CARL J. SEIDEN is currently a Managing Director with JP Morgan where he
is the Senior Analyst responsible for equity research on the US
Pharmaceutical Industry. He joined JP Morgan's equity research
department in 1997, having covered the pharmaceutical industry at
Sanford C. Bernstein & Co. since 1992. Mr. Seiden was named to the
Institutional Investor All-American Analyst Team in 2000, 1999, 1998 and
1994. He was employed at Squibb and Bristol-Myers Squibb from 1987 to
1992 including positions in strategic planning, business development and
managed health care. His last position was Director of Managed Health
Care operations, where he represented nine BMS pharmaceutical and
nutritional divisions to a select group of managed care customers,
including HMOs, hospital systems, and pharmacy benefit management
companies. From 1984 to 1987 he was a Senior Managing Consultant in
General Electric's corporate marketing department, where he was
responsible for managing marketing consulting projects for GE divisional
clients. This included significant project work for GE Medical Systems '
a world-leading manufacturer of MRIs, CT-scanners and other specialized
imaging technologies. From 1980 to 1982. Carl was a Scientific Sales
Representative for VWR Scientific. Mr. Seiden earned an MBA from the
Wharton School of Business, University of Pennsylvania, in 1984 and a
Bachelor of Science in Biology from Union College in Schenectady NY in
1980. Profile
set the stage for the next 12 months, and what can we expect out of the
next 12 months?
Mr. Seiden: The pharmaceutical
